Survival after aortic valve replacement forsevere aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction
Jeremy J. Pereira, MB, BS*,
Michael S. Lauer, MD, FACC*,
Mohammad Bashir, MB, BS*,
Imran Afridi, MD, FACC*,
Eugene H. Blackstone, MD, FACC ,
William J. Stewart, MD, FACC*,
Patrick M. McCarthy, MD ,
James D. Thomas, MD, FACC* and
Craig R. Asher, MD, FACC*,*
* Departments of Cardiology, Cleveland Clinic Foundation, Cleveland, OhioUSA
Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, OhioUSA
Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, OhioUSA
View larger version (14K):
[in a new window]
|
Figure 1 Survival by Kaplan-Meier analysis among all patients in the aortic valve replacement (AVR) and control (No AVR) groups (p < 0.0001). The number of patients at risk during follow-up is shown on the x axis. Echo = echocardiography.
|
|
View larger version (13K):
[in a new window]
|
Figure 2 Survival by Kaplan-Meier analysis among all propensity-matched patients in the aortic valve replacement (AVR) and control (No AVR) groups (p < 0.0001). The number of patients at risk during follow-up is shown on the x axis. Echo = echocardiography.
|
|
View larger version (50K):
[in a new window]
|
Figure 3 Change in New York Heart Association (NYHA) functional class symptoms in 44 of 46 late survivors in the aortic valve replacement (AVR) group (p < 0.001 for change in NYHA functional class III/IV symptoms, preoperatively and postoperatively). N = number of patients.
|
|
|
